A medical device company acquired a patent for ultrasound technology when it purchased all the assets of a defunct health research corporation, the Delaware Court of Chancery has ruled. In awarding the patent’s ownership, the court also denied its claim to a second, similar patent, ruling that it did not present enough evidence regarding the technology’s conception.
Vice Chancellor John W. Noble issued the 48-page opinion in ReCor Medical v. Warnking. The decision was an unusual one for the Chancery Court because patent disputes among Delaware corporations are typically resolved by the U.S. District Court for the District of Delaware. However, this case was viewed by the court as a contractual claim instead of a patent issue.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
